Arixtra and Cardiac failure aggravated - a phase IV clinical study of FDA data

Summary:

Cardiac failure aggravated is reported as a side effect among people who take Arixtra (fondaparinux sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Furosemide, and have High blood pressure.

The phase IV clinical study analyzes which people have Cardiac failure aggravated when taking Arixtra. It is created by eHealthMe based on reports of 9,755 people who have side effects when taking Arixtra from the FDA, and is updated regularly.

What is Arixtra?

Arixtra has active ingredients of fondaparinux sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 9,830 Arixtra users. Check the latest studies of Arixtra.

What is Cardiac failure aggravated?

Cardiac failure aggravated is found to be associated with 1,826 drugs and 760 conditions by eHealthMe. Check the latest studies of Cardiac failure aggravated.

On Jul, 26, 2026

9,755 people reported to have side effects when taking Arixtra.
Among them, 63 people (0.65%) have Cardiac failure aggravated.

Could Arixtra cause Cardiac failure aggravated?

Among these 63 people:

How long have people been on Arixtra when they have Cardiac failure aggravated? *

What is the gender of people who have Cardiac failure aggravated when taking Arixtra? *

female: 69.35 %
male: 30.65 %

What is the age of people who have Cardiac failure aggravated when taking Arixtra? *

What are other drugs people take besides Arixtra? *

What are other side effects people have besides Cardiac failure aggravated? *

Anaemia (lack of blood): 13 people, 20.63%
Oedema Peripheral (superficial swelling): 9 people, 14.29%
Dyspnea (difficult or laboured breathing): 7 people, 11.11%
Pneumonia: 7 people, 11.11%
Pulmonary Oedema (fluid accumulation in the lungs): 7 people, 11.11%
Rashes (redness): 7 people, 11.11%
Hypotension (abnormally low blood pressure): 7 people, 11.11%
Chest Pain: 7 people, 11.11%
Pain: 6 people, 9.52%
Oedema (fluid collection in tissue): 6 people, 9.52%

What are the existing conditions these people have? *

High Blood Pressure: 10 people, 15.87%
Agitation (state of anxiety or nervous excitement): 6 people, 9.52%
Multiple Myeloma (cancer of the plasma cells): 5 people, 7.94%
Breast Cancer: 5 people, 7.94%
Asthma: 4 people, 6.35%
Pulmonary Embolism (blockage of the main artery of the lung): 4 people, 6.35%
Nausea And Vomiting: 4 people, 6.35%
Pain: 3 people, 4.76%
Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 4.76%
Essential Hypertension (primary hypertension): 3 people, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Arixtra and have Cardiac failure aggravated?

- Check whether Cardiac failure aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Arixtra:

Arixtra (9,830 reports)

Browse all side effects of Arixtra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardiac failure aggravated:

Cardiac failure aggravated (1,826 drugs)

Browse all the conditions that are associated with Cardiac failure aggravated:

Cardiac failure aggravated (760 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fondaparinux sodium (the active ingredients of Arixtra) and Arixtra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.